NOV 03, 2016 10:30 AM PDT

The High Resolution Solution: Accurate Mass for the Clinical Research Laboratory

Speaker
  • R&D Specialist, ARUP
    Biography
      Natalie Rasmussen grew up in the Salt Lake City, UT area and earned a BS in biology from the University of Utah in 2004. She began working in the toxicology area at ARUP Laboratories in 2005, where she prepared samples and analyzed them via immunoassay and mass spectrometry. Natalie accepted a position as research and development specialist in ARUP's Institute for Clinical and Experimental Pathology in 2012, where she primarily works on Time-of-Flight mass spec-based testing. She also has some experience with immunoassay and MADLI-TOF. In her free time, she enjoys exploring the playground that is Utah by hiking and camping. She also enjoys reading, cooking, playing softball, and attending sporting events, especially at the University of Utah.

    Abstract

    Liquid chromatography high resolution time-of-flight mass spectrometry (LC-TOF-MS) is becoming increasingly popular in the clinical research laboratory. It can offer higher throughput and superior specificity to the more traditional tandem mass spectrometry (LC-MS/MS) methods. In addition, LC-TOF-MS has the ability to collect full scan data, which allows for down-stream data mining. This talk will discuss time-of-fight mass spectrometry fundamentals; including theory, method development strategies, pros and cons of LC-TOF-MS as compared to LC-MS/MS, and a few lessons our laboratory has learned along the way. 

    Learning Objectives:

    • Describe how time-of-flight mass spectrometry works
    • Compare and contrast TOF-MS with LC-MS/MS
    • Assess what you will need in order to integrate TOF-MS into your laboratory


    For Research Use Only. Not for use in diagnostic procedures.
     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    Loading Comments...
    Show Resources
    Attendees
    • See more